Report

BABA FY1Q24 Results: User Growth Drives Topline

What's new: Alibaba’s reported FY1Q24 results top consensus and our expectations. Taobao and Tmall Group would continue its virtuous investment cycle to improve user mindshare and merchant wallet share over time. We maintain our PT at USD150.

Analysts:
Jin Yoon
Underlyings
AAREY DRUGS & PHARMACEUTICALS LTD

Aarey Drugs & Pharmaceuticals Limited is engaged in active pharmaceutical ingredient (API)/Bulk Drugs manufacturing and offers a range of products for various industrial applications. The Company is engaged in trading and manufacturing activities. The Company is a manufacturer and supplier of pharmaceutical raw materials, chemicals, pharmaceutical ingredients, API's drugs, food colors and flavors. The Company's assortment of pharmaceutical products includes Metronidazole and Metronidazole Benzoate. Its products include Monomethyl Urea (MMU, Dimethyl Urea (DMU), Theobromine (THB), Theophylline (THP) and Pentoxifylline (PTF). Its other businesses include aromatics chemical, chemical acid, chlor alkalis, industrial alcohols, industrial ketones, glycols and glycol ethers, fiber intermediates, industrial amines, acetates and esters, chlorinated solvents, industrial intermediates and industrial chemicals.

Alibaba Group Holding Ltd. Sponsored ADR

Provider
New Street Research
New Street Research

Provided by our team of experienced analysts, our work is idea driven, based on independence of thought, sector expertise, and firmly focussed on fundamentals and valuation.

New Street Research is an independent, partner-owned, research firm specialising in equity and debt research. Our equity research embraces the following sectors:

  • Pan European Telecom Services and Cable
  • US Telecoms, Cable, Satellite and Towers
  • Global Emerging Market Telecoms
  • Japan Telecoms
  • Asian Internet
  • Pan European Healthcare
  • Global healthcare thematic research

We provide debt research on:

  • Pan European Telecom Services and Cable


Analysts
Jin Yoon

Other Reports on these Companies
Other Reports from New Street Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch